BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

3 Months Ended

Mar. 31, 2017

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three months ended March 31, 2017 and 2016 are as follows:

	Three Months Ended
	March 31,
	2017				2016
Laser systems		61.9	%			62.3	%
Imaging systems		5.7	%			6.3	%
Consumables and other		15.6	%			16.1	%
Services		16.5	%			15.0	%
License fees and royalties		0.3	%			0.3	%
Total revenue		100.0	%			100.0	%